The Stanford REACH Lab's SMART TALK: Cannabis Awareness and Prevention Toolkit is a free, online educational resource to be used by educators to increase knowledge and awareness of cannabis and reduce use among youth. The aim of this study is to investigate the extent to which the curriculum changes middle and high school students' intentions to use and actual use of cannabis.
Smart Talk includes 5 lessons, each providing activities, online quiz games, and worksheets in addition to presentations, resources, and other materials aimed at addressing key factors associated with youth cannabis use, including changing adolescents' attitudes towards and misperceptions about cannabis; increasing their refusal skills to pulls of marketing and social media; reducing stress and depression which have been linked to cannabis initiation and use; improving coping skills; and decreasing intentions and actual use of all cannabis products.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
10,800
Behavioral:Smart Talk includes 5 lessons, each providing activities, online quiz games, and worksheets in addition to presentations, resources, and other materials aimed at addressing key factors associated with youth cannabis use, including changing adolescents' attitudes towards and misperceptions about cannabis; increasing their refusal skills to pulls of marketing and social media; reducing stress and depression which have been linked to cannabis initiation and use; improving coping skills; and decreasing intentions and actual use of all cannabis products.
Stanford University
Palo Alto, California, United States
Change in cannabis use
Investigator-originated survey measures (questions) assess ever cannabis use \& past 30-day cannabis use. This outcome measure assesses cannabis use.
Time frame: Baseline to follow-up at approximately 182 weeks
Change in intention to use cannabis in the future
Investigator-originated survey measures (questions) assessing change in participant intention to use cannabis in the future
Time frame: Baseline to follow-up at approximately 182 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.